Latest News
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The New York Times about some common questions and misconceptions about antidepressants. Sanacora is director of the Yale Depression Research Program.
- October 24, 2024Source: Yale Medicine
A Yale psychiatrist answers questions about electroconvulsive therapy (ECT), a psychiatric treatment that involves sending electrical currents through the brain.
- October 03, 2024Source: Yale Daily News
In this article addressing data from the Centers for Disease Control and Prevention showing that the national suicide rate increased by 30 percent over the past two decades, Yale faculty including YCSC experts provide additional insight into this growing problem along with information about prevention efforts.
- October 02, 2024
A small sample of patients with bipolar disorder displayed noteworthy improvement in their depressive symptoms after being treated with the rapid-acting antidepressant intravenous ketamine and the nasal spray esketamine, according to a new Yale led-study. Mia Santucci, BA, postgraduate associate, and Samuel Wilkinson, MD, associate professor of psychiatry, are lead and senior authors, respectively.
- August 20, 2024Source: The Wall Street Journal
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The Wall Street Journal about ketamine's effect on the brain and why it can work as an antidepressant.
- May 23, 2024Source: Psychology Today
Benjamin Kelmendi, MD, assistant professor of psychiatry, writes in Psychology Today about the new dimension psychedelic-assisted therapies bring to questions about subjectivity in psychiatry.
- May 02, 2024Source: The New England Journal of Medicine
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry; and Sina Nikayin, MD, assistant professor of psychiatry, are featured in the first episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine.
- April 03, 2024Source: Psychology Today
Samuel Wilkinson, MD, associate professor of psychiatry and associate director of the Yale Depression Research Program, writes in Psychology Today about the history of ketamine, its use to treat depression, and how it compares to esketamine.
- March 25, 2024Source: CNN
Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry and director of the Yale Depression Research Program, spoke to CNN about the use of ketamine to treat anxiety and depression.
- March 05, 2024
Samuel T. Wilkinson, MD, associate professor of psychiatry, is author of the new book "Purpose: What Evolution And Human Nature Imply About the Meaning of Our Existence?"